Keros Therapeutics (KROS) Cash flow

365 Followers

Keros Therapeutics Cash Flow

KROS's free cash flow for Q1 2026 was $-3.60M. For the 2026 fiscal year, KROS's free cash flow was decreased by $268.75M and operating cash flow was $-3.53M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 107.50M	$ -160.87M	$ -124.51M	$ -70.06M	$ -62.15M
Investing Cash Flow	$ -1.55M	$ -1.93M	$ -2.46M	$ -1.24M	$ -1.02M
Financing Cash Flow	$ -378.47M	$ 391.82M	$ 178.96M	$ 120.31M	$ 28.55M
End Cash Position	$ 288.86M	$ 561.38M	$ 332.36M	$ 280.38M	$ 231.37M
Free Cash Flow	$ 105.95M	$ -162.80M	$ -126.97M	$ -71.30M	$ -63.17M

Currency in USD